PLRX · NASDAQ · Biotechnology

Pliant Therapeutics

Develops integrin-targeted medicines and delivery technologies after its fibrosis-program reset.

$1.12
After-hours close+0.01 (+0.54%)
At close$1.11(−3.48%)

Breakdown13F · Form 4

Institutions 80.23%49.68M sharesInsiders 1.43%885.5K sharesOther 18.34%11.35M shares

Shares outstanding 61.92M · Float 57.32M · 92.6% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Tang Capital Management LLC6.14M9.92%13FMay 15, 2026
ADAR1 Capital Management, LLC5.51M8.90%13GAug 14, 2026
Citadel Advisors LLC3.23M5.21%13FMay 15, 2026
Jeremy C. Green3.20M5.30%13GNov 14, 2024
Blue Owl Capital Holdings LP2.97M4.80%13FMay 14, 2026

Institutions13F, as of Mar 31, 2026

94 holders · 49.68M shares · 14 new positions · 38 increased · 27 reduced · 19 closed

HolderShares% outstandingChg q/qFiled
Tang Capital Management LLC6.14M9.92%0May 15, 2026
Citadel Advisors LLC3.23M5.21%+643.3KMay 15, 2026
Blue Owl Capital Holdings LP2.97M4.80%0May 14, 2026
Adar1 Capital Management, LLC2.59M4.17%+2.51MMay 18, 2026
Acadian Asset Management LLC2.42M3.90%+51.8KMay 13, 2026
Vanguard Capital Management LLC2.34M3.78%+2.34MnewMay 15, 2026
Two Sigma Investments, LP2.25M3.64%+1.30MMay 15, 2026
Monaco Asset Management Sam1.94M3.13%0May 11, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Tang Capital Management, LLCincl. Tang Capital Partners International, LP, Tang Capital Partners Iii, Inc +4 more9.60%5.86M13DMar 10, 2025
ADAR1 Capital Management, LLC8.90%5.51M13GAug 14, 2026
Jeremy C. Greenincl. Redmile Group, LLC5.30%3.20M13GNov 14, 2024

InsidersForm 4

InsiderRoleShares% outstandingFiled
Bernard Couliedirector, officer: President and CEO505.6K0.82%Jan 22, 2026
Keith Lamont Cummingsofficer: Chief Financial Officer297.2K0.48%Jan 22, 2026
Lily Cheungofficer: Chief Human Resource Officer44.8K0.07%Jan 22, 2026
Minnie Kuoofficer: Chief Operating Officer37.8K0.06%Jan 22, 2026

1 ten-percent owner holds 1.91M shares by Form 4, outside the officers-and-directors figure above · 9 people have not refiled in the last 18 months (2.84M shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Jan 20, 2026
Minnie Kuoofficer: Chief Operating Officer
Sale6,917$1.2837,806
Jan 20, 2026
Bernard Couliedirector, officer: President and CEO
Sale89,375$1.28505,601
Jan 20, 2026
Lily Cheungofficer: Chief Human Resource Officer
Sale7,534$1.2844,847
Jan 20, 2026
Keith Lamont Cummingsofficer: Chief Financial Officer
Sale24,002$1.28297,214

CongressHouse and Senate disclosures

Not reported.